Oscar Health, Inc. (OSCR)

SpringWorks Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	123.34	25.43	-270.73	-606.28	-572.61	-406.83
Depreciation & Amortization	31.06	32.15	30.69	15.28	14.61	11.29
Other Amortization	0.78	0.78	0.78	0.71	0.33	0.33
Gain (Loss) on Sale of Investments	-28.32	-26.88	-29.37	2.48	8.03	2.59
Stock-Based Compensation	108.85	109.82	159.68	112.33	86.3	35.87
Change in Accounts Receivable	-137.91	-114.32	-13.41	-81.05	-66.95	-35.25
Reinsurance Recoverable	55.39	-50.34	651.69	-460.9	147.4	-63.33
Change in Accounts Payable	323.92	152.77	-29.18	57.81	98.62	75.8
Change in Unearned Revenue	5.36	8.47	-13.08	3.95	3.14	46.6
Change in Insurance Reserves / Liabilities	-4.33	-5.78	1.56	-25.03	-55.33	71.82
Change in Other Net Operating Assets	792.04	867.74	-423.05	1,138	258.89	569.27
Other Operating Activities	-1.56	-1.67	0.26	-2.17	33.9	3.79
Operating Cash Flow	1,222	978.19	-272.16	380.35	-181.75	222.73
Capital Expenditures	-30.97	-27.9	-25.58	-29.01	-25.89	-14.02
Investment in Securities	-1,233	-1,363	605.04	-198.62	-755.31	-329.45
Other Investing Activities	3.3	3.93	-2.28	1.12	6.68	-1.24
Investing Cash Flow	-1,261	-1,387	577.19	-226.52	-774.52	-344.71
Long-Term Debt Issued	-	-	-	305	-	147
Total Debt Repaid	-	-	-	-	-153.17	-
Net Debt Issued (Repaid)	-	-	-	305	-153.17	147
Issuance of Common Stock	46.81	68.39	6.45	3.15	1,407	93.88
Repurchases of Common Stock	-0.86	-	-	-	-	-
Issuance of Preferred Stock	-	-	-	-	-	375.67
Other Financing Activities	-	-	-	-7.04	-15.21	-4.84
Financing Cash Flow	45.95	68.39	6.45	301.11	1,239	611.71
Net Cash Flow	7.25	-340.85	311.47	454.94	282.45	489.73
Free Cash Flow	1,191	950.3	-297.74	351.34	-207.63	208.71
Free Cash Flow Margin	11.82%	10.36%	-5.08%	8.86%	-10.96%	53.38%
Free Cash Flow Per Share	4.43	3.58	-1.34	1.65	-1.16	7.13
Cash Interest Paid	22.73	33.69	23.16	10.08	4.26	-
Cash Income Tax Paid	0.67	0.67	2.41	1.89	0.7	1.53
Levered Free Cash Flow	1,065	1,043	567.79	-230.88	-253.85	320.28
Unlevered Free Cash Flow	1,079	1,058	582.39	-217.46	-251.23	322.15
Change in Net Working Capital	-864.2	-907.65	-535.91	-52.61	-14.05	-540.44

Updated May 7, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q